Freeze Whitney Marilyn, Van Veluw Susanne Janneke, Jansen Willemijn Josepha, Bennett David Alan, Jacobs Heidi Irma Louisa
Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
Department of Psychiatry and Neuropsychology, Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
Alzheimers Dement. 2023 Nov;19(11):5023-5035. doi: 10.1002/alz.13096. Epub 2023 Apr 24.
We investigated the link between locus coeruleus (LC) pathology and cerebral microangiopathy in two large neuropathology datasets.
We included data from the National Alzheimer's Coordinating Center (NACC) database (n = 2197) and Religious Orders Study and Rush Memory and Aging Project (ROSMAP; n = 1637). Generalized estimating equations and logistic regression were used to examine associations between LC hypopigmentation and presence of cerebral amyloid angiopathy (CAA) or arteriolosclerosis, correcting for age at death, sex, cortical Alzheimer's disease (AD) pathology, ante mortem cognitive status, and presence of vascular and genetic risk factors.
LC hypopigmentation was associated with higher odds of overall CAA in the NACC dataset, leptomeningeal CAA in the ROSMAP dataset, and arteriolosclerosis in both datasets.
LC pathology is associated with cerebral microangiopathy, independent of cortical AD pathology. LC degeneration could potentially contribute to the pathways relating vascular pathology to AD. Future studies of the LC-norepinephrine system on cerebrovascular health are warranted.
We associated locus coeruleus (LC) pathology and cerebral microangiopathy in two large autopsy datasets. LC hypopigmentation was consistently related to arteriolosclerosis in both datasets. LC hypopigmentation was related to cerebral amyloid angiopathy (CAA) presence in the National Alzheimer's Coordinating Center dataset. LC hypopigmentation was related to leptomeningeal CAA in the Religious Orders Study and Rush Memory and Aging Project dataset. LC degeneration may play a role in the pathways relating vascular pathology to Alzheimer's disease.
我们在两个大型神经病理学数据集中研究了蓝斑(LC)病理学与脑微血管病之间的联系。
我们纳入了来自国家阿尔茨海默病协调中心(NACC)数据库(n = 2197)以及宗教团体研究与拉什记忆与衰老项目(ROSMAP;n = 1637)的数据。使用广义估计方程和逻辑回归来检验LC色素减退与脑淀粉样血管病(CAA)或小动脉硬化的存在之间的关联,并对死亡年龄、性别、皮质阿尔茨海默病(AD)病理学、生前认知状态以及血管和遗传风险因素的存在进行校正。
在NACC数据集中,LC色素减退与总体CAA的较高几率相关;在ROSMAP数据集中,与软脑膜CAA相关;在两个数据集中均与小动脉硬化相关。
LC病理学与脑微血管病相关,独立于皮质AD病理学。LC变性可能潜在地促成血管病理学与AD相关的途径。未来有必要对LC - 去甲肾上腺素系统对脑血管健康的影响进行研究。
我们在两个大型尸检数据集中关联了蓝斑(LC)病理学与脑微血管病。在两个数据集中,LC色素减退均与小动脉硬化持续相关。在国家阿尔茨海默病协调中心数据集中,LC色素减退与脑淀粉样血管病(CAA)的存在相关。在宗教团体研究与拉什记忆与衰老项目数据集中,LC色素减退与软脑膜CAA相关。LC变性可能在血管病理学与阿尔茨海默病相关的途径中起作用。